Cargando…

Levels of soluble fibrin in severe septic patients given intravenous immunoglobulin

Detalles Bibliográficos
Autores principales:	Kobayashi, T, Nishiura, T, Suga, H, Nakagawa, T
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084209/ http://dx.doi.org/10.1186/cc7487

Ejemplares similares

Effect of intravenous administration of freeze-dried sulfonated human normal immunoglobulin for septic patients
por: Deguchi, Y, et al.
Publicado: (2009)

Clinical usefulness of measurement of plasma soluble fibrin levels in critically ill patients
por: Masuda, T, et al.
Publicado: (2014)

Comparative study between intravenous immunoglobulins and standard treatment in septic patients
por: Hamed, G, et al.
Publicado: (2008)

Use of intravenous and intramuscular immunoglobulin in the practice of treatment for purulent and septic deaths in newborns
por: Khanes, G, et al.
Publicado: (2012)

Sulfonated immunoglobulin improves cardiopulmonary functions by promoting IGF-I production in ARDS patients with severe sepsis
por: Deguchi, Y, et al.
Publicado: (2011)

Prediction of the development of organ failures in patients with systemic inflammatory response syndrome by determination of plasma levels of soluble E-selectin
por: Okajima, K, et al.
Publicado: (2004)

Kinetics of immunoglobulins in septic shock patients
por: Siqueira, C, et al.
Publicado: (2011)

Low dose immunoglobulin g for treatment of severe sepsis and septic shock
por: Iizuka, Y, et al.
Publicado: (2015)

Intravenous immunoglobulin therapy could have efficacy in severe sepsis
por: Kim, Ahmin, et al.
Publicado: (2013)

Early use of immunoglobulin in septic shock
por: Cavazzuti, IC, et al.
Publicado: (2010)

Low levels of immunoglobulin G in patients with sepsis or septic shock: a signum mali ominis?
por: Dietz, S, et al.
Publicado: (2010)

Changes in procalcitonin and presepsin before and after immunoglobulin administration in septic patients
por: Ikeda, T, et al.
Publicado: (2015)

Outcome in severe sepsis and septic shock patients with hematological malignancies: impact of recent intravenous chemotherapeutic treatment
por: Vandijck, D, et al.
Publicado: (2008)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2011)

Usefulness of intravenous immunoglobulin administration to sepsis-induced coagulopathy in ICU patients
por: Matsumoto, N, et al.
Publicado: (2014)

Assessment of the usefulness of presepsin (soluble CD14 subtype) in septic patients
por: Nishida, T, et al.
Publicado: (2012)

Newly developed plasma soluble E-selectin rapid assay predicts prevalence of acute respiratory distress syndrome in critically ill patients
por: Okajima, K, et al.
Publicado: (2006)

Inhaled and intravenous application of a stimulator of the soluble guanylate cyclase (BAY 41-8543) reduces pulmonary vascular resistance in a model of septic shock
por: Kronas, Nils, et al.
Publicado: (2011)

Use of Intravenous Immunoglobulin Therapy in a paediatric rheumatology service
por: Saladi, SM, et al.
Publicado: (2008)

Use of intravenous immunoglobulin to treat sepsis in a general ICU
por: Drakeford, Y, et al.
Publicado: (2015)

Total homocysteine plasmatic levels as a marker of clinical severity in septic patients
por: Coelho Neto, AA, et al.
Publicado: (2005)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
por: Baskin, E, et al.
Publicado: (2008)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Intravenous immunoglobulins prevent breakdown of the blood-brain barrier in experimental sepsis
por: Esen, F, et al.
Publicado: (2010)

Clinical efficacy of recombinant human soluble thrombomodulin in patients with septic disseminated intravascular coagulation
por: Suzuki, Y, et al.
Publicado: (2013)

Evaluation of iron, transferrin and ferritin serum levels in patients with severe sepsis and septic shock
por: Missano Florido, M, et al.
Publicado: (2012)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Igm-enriched polyclonal immunoglobulins in an experimental model of gram negative pneumonia developing septic shock
por: Vaschetto, R, et al.
Publicado: (2015)

Homocysteine levels in septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Cytokine levels is septic shock
por: Mateu Campos, L, et al.
Publicado: (2015)

Microcirculation and intravascular coagulopathy in patients with severe sepsis and septic shock
por: Wimmer, R, et al.
Publicado: (2010)

Lactate levels from arterial, central venous and peripheral venous blood in severe sepsis and septic shock patients
por: Assuncao, M, et al.
Publicado: (2007)

Standard operating procedure in patients with severe sepsis and septic shock
por: Schwab, T, et al.
Publicado: (2009)

Effects of administration of dexmedetomidine on inflammatory responses and severity in severe septic patients
por: Taniguchi, T, et al.
Publicado: (2015)

Functional protein C levels in septic patients
por: Lafuente, E, et al.
Publicado: (2007)

Sublingual leukocyte activation in patients with severe sepsis or septic shock
por: Fabian-Jessing, BK, et al.
Publicado: (2015)

Association between apoptosis and mortality in severe septic patients
por: Lorente, L, et al.
Publicado: (2015)

Prehospital administered intravenous antimicrobial protocol for septic shock: a prospective randomized clinical trial
por: Chamberlain, D
Publicado: (2009)

Lymphocyte phenotype during severe sepsis and septic shock
por: Le Dorze, M, et al.
Publicado: (2015)

High incidence of adrenal suppression in children with Kawasaki disease treated with intravenous immunoglobulin plus prednisolone
por: Goto, Masahiro, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_qq8cjj8jh39qu06tr2qehr8t8q